Cetuximab for the first-line treatment of metastatic colorectal cancer.

C. Meads*, J. Round, S. Tubeuf, D Moore, M. Pennant, S. Bayliss

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cetuximab for the first-line treatment of metastatic colorectal cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences